Resonant Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $421K | Sell |
|
|||||
|
2025
Q2 | $560K | Buy |
|
|||||
|
2025
Q1 | $554K | Buy |
|
|||||
|
2024
Q4 | $585K | Sell |
|
|||||
|
2024
Q3 | $839K | Buy |
|
|||||
|
2024
Q2 | $976K | Buy |
|
|||||
|
2024
Q1 | $764K | Buy |
|
|||||
|
2023
Q4 | $322K | Sell |
|
|||||
|
2023
Q3 | $302K | Sell |
|
|||||
|
2023
Q2 | $308K | Hold |
|
|||||
|
2023
Q1 | $305K | Hold |
|
|||||
|
2022
Q4 | $258K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $212K | Sell |
|
|||||
|
2022
Q1 | $245K | Buy |
|
|||||
|
2021
Q4 | $205K | Buy |
|